Amdipharm Mercury Australia Pty Ltd

62 result(s) found, displaying 1 to 10

MYTOLAC lanreotide (as acetate) 60 mg solution for injection pre-filled syringe (371881)

10 August 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MYTOLAC lanreotide (as acetate) 60 mg solution for injection pre-filled syringe.
MYTOLAC lanreotide (as acetate) 90 mg solution for injection pre-filled syringe (371880)

10 August 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MYTOLAC lanreotide (as acetate) 90 mg solution for injection pre-filled syringe.
MYTOLAC lanreotide (as acetate) 120 mg solution for injection pre-filled syringe (371879)

10 August 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MYTOLAC lanreotide (as acetate) 120 mg solution for injection pre-filled syringe.
MYTOLAC (Amdipharm Mercury Australia Pty Ltd)

8 August 2022

Prescription medicine registration

Active ingredients: Lanreotide acetate.
AKINETON biperiden hydrochloride 2mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2021

Cancellation by sponsor

Requested by Amdipharm Mercury Australia Pty Ltd
EES erythromycin (as ethyl succinate) 400mg/5mL granules for oral liquid bottle Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Amdipharm Mercury Australia Pty Ltd
EES 400 erythromycin 400mg (as ethyl succinate) tablet bottle Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Amdipharm Mercury Australia Pty Ltd
STELAZINE trifluoperazine 1mg (as hydrochloride) tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Amdipharm Mercury Australia Pty Ltd
STELAZINE trifluoperazine 2mg (as hydrochloride) tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Amdipharm Mercury Australia Pty Ltd
STELAZINE trifluoperazine 5mg (as hydrochloride) tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Amdipharm Mercury Australia Pty Ltd

Sub menu

Amdipharm Mercury Australia Pty Ltd

MYTOLAC lanreotide (as acetate) 60 mg solution for injection pre-filled syringe (371881)

MYTOLAC lanreotide (as acetate) 90 mg solution for injection pre-filled syringe (371880)

MYTOLAC lanreotide (as acetate) 120 mg solution for injection pre-filled syringe (371879)

MYTOLAC (Amdipharm Mercury Australia Pty Ltd)

AKINETON biperiden hydrochloride 2mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

EES erythromycin (as ethyl succinate) 400mg/5mL granules for oral liquid bottle Cancelled under Section 30(1)(c) of the Act

EES 400 erythromycin 400mg (as ethyl succinate) tablet bottle Cancelled under Section 30(1)(c) of the Act

STELAZINE trifluoperazine 1mg (as hydrochloride) tablet blister pack Cancelled under Section 30(1)(c) of the Act

STELAZINE trifluoperazine 2mg (as hydrochloride) tablet blister pack Cancelled under Section 30(1)(c) of the Act

STELAZINE trifluoperazine 5mg (as hydrochloride) tablet blister pack Cancelled under Section 30(1)(c) of the Act

Help us improve the Therapeutic Goods Administration site

Amdipharm Mercury Australia Pty Ltd

Type

Date

Help us improve the Therapeutic Goods Administration site